The emerging role of darbepoetin alfa in the management of patients with cancer.
Gordon
Michael S
MS
D000740:Anemia / Q000139:chemically induced / Q000188:drug therapy*; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000097:blood; D016207:Cytokines / Q000008:administration & dosage / Q000627:therapeutic use; D000068256:Darbepoetin alfa; D004921:Erythropoietin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008495:Medical Oncology / Q000639:trends; D009369:Neoplasms / Q000188:drug therapy
D000970:Antineoplastic Agents; D016207:Cytokines; D004921:Erythropoietin; D000068256:Darbepoetin alfa